About the Company - Dishman Carbogen Amcis Ltd
Dishman Carbogen Amcis Ltd. is a Public Limited Listed company incorporated on 17/07/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L74900GJ2007PLC051338 and registration number is 051338. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 302.79 Cr. and Equity Capital is Rs. 31.36 Cr. for the Year ended 31/03/2022.
Management |
---|
Name | Position Held |
---|
Mr. Janmejay R Vyas | Chairman |
Mr. Arpit J Vyas | Global Managing Director |
Mrs. Deohooti J Vyas | Whole Time Director |
Mr. Sanjay S Majmudar | Independent Director |
Mr. Ashok C Gandhi | Independent Director |
Mr. Rajendra S Shah | Independent Director |
Mr. Subir Kumar Das | Independent Director |
Mr. Maitri K Mehta | Director |
Dishman Carbogen Amcis Ltd. Share Price Update |
---|
Share Price | Value |
---|
Today | ₹168.35 |
Previous Day | ₹167.70 |
Basic Stock Data of Dishman Carbogen Amcis Ltd
Market Cap | 2,637 Cr. |
---|
Current Price | 168 |
---|
High / Low | 179/80.0 |
---|
Stock P/E | 1,122 |
---|
Book Value | 368 |
---|
Dividend Yield | 0.00 % |
---|
ROCE | 1.03 % |
---|
ROE | 0.15 % |
---|
Face Value | 2.00 |
---|
Dishman Carbogen Amcis Ltd Quarterly Results
Month | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|
Sales | 439 | 469 | 529 | 551 | 459 | 562 | 569 | 541 | 614 | 640 | 619 | 723 | 587 |
Expenses | 359 | 406 | 441 | 450 | 360 | 453 | 547 | 452 | 535 | 526 | 567 | 602 | 526 |
Operating Profit | 80 | 63 | 88 | 101 | 99 | 110 | 22 | 88 | 79 | 114 | 51 | 122 | 61 |
OPM % | 18% | 13% | 17% | 18% | 22% | 19% | 4% | 16% | 13% | 18% | 8% | 17% | 10% |
Other Income | 15 | 9 | -16 | 10 | 7 | 19 | -8 | 6 | 9 | 4 | -39 | 7 | 5 |
Interest | 13 | 14 | 9 | 12 | 14 | 15 | 16 | 19 | 20 | 22 | 24 | 28 | 27 |
Depreciation | 78 | 79 | 77 | 75 | 74 | 75 | 84 | 75 | 80 | 50 | 76 | 70 | 75 |
Profit before tax | 4 | -22 | -14 | 24 | 19 | 38 | -85 | -0 | -12 | 46 | -88 | 29 | -36 |
Tax % | -86% | 27% | -879% | 33% | 40% | 8% | 48% | 1,437% | 18% | -3% | 19% | 42% | -13% |
Net Profit | 7 | -16 | -135 | 16 | 11 | 35 | -45 | 4 | -10 | 47 | -71 | 17 | -41 |
EPS in Rs | 0.47 | -1.02 | -8.61 | 1.02 | 0.71 | 2.26 | -2.85 | 0.26 | -0.64 | 3.00 | -4.51 | 1.08 | -2.61 |
Dishman Carbogen Amcis Ltd Quarterly Chart
Dishman Carbogen Amcis Ltd Profit & Loss
Month | Mar 2011 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|
Sales | 1,031 | 1,714 | 1,695 | 2,059 | 2,044 | 1,912 | 2,141 | 2,413 | 2,568 |
Expenses | 830 | 1,261 | 1,249 | 1,507 | 1,540 | 1,638 | 1,809 | 2,081 | 2,220 |
Operating Profit | 201 | 452 | 445 | 552 | 503 | 274 | 331 | 332 | 348 |
OPM % | 20% | 26% | 26% | 27% | 25% | 14% | 15% | 14% | 14% |
Other Income | 14 | 26 | 46 | 54 | 39 | 16 | 29 | -20 | -23 |
Interest | 56 | 49 | 49 | 57 | 62 | 48 | 57 | 86 | 102 |
Depreciation | 69 | 214 | 211 | 240 | 283 | 308 | 308 | 281 | 272 |
Profit before tax | 91 | 216 | 231 | 309 | 197 | -65 | -4 | -55 | -49 |
Tax % | 12% | 33% | 33% | 32% | 20% | -154% | 524% | 45% | |
Net Profit | 80 | 145 | 155 | 210 | 159 | -165 | 18 | -30 | -48 |
EPS in Rs | | | 9.58 | 13.03 | 10.10 | -10.53 | 1.15 | -1.90 | -3.04 |
Dividend Payout % | 0% | 0% | 0% | 2% | 0% | 0% | 0% | 0% | |
Dishman Carbogen Amcis Ltd Profit & Loss Yearly Chart
Dishman Carbogen Amcis Ltd Growth
|
Compounded Sales Growth |
---|
10 Years:: | % |
5 Years:: | 7% |
3 Years:: | 6% |
TTM:: | 12% |
Dishman Carbogen Amcis Ltd Growth
|
Compounded Profit Growth |
---|
10 Years:: | % |
5 Years:: | % |
3 Years:: | % |
TTM:: | 175% |
Dishman Carbogen Amcis Ltd Growth
|
Stock Price CAGR |
---|
10 Years:: | % |
5 Years:: | -7% |
3 Years:: | 5% |
1 Year:: | 71% |
Dishman Carbogen Amcis Ltd Growth
|
Return on Equity |
---|
10 Years:: | % |
5 Years:: | 1% |
3 Years:: | -1% |
Last Year:: | 0% |
No data available for the Balance Sheet data table.
Dishman Carbogen Amcis Ltd Reserves and Borrowings Chart
Dishman Carbogen Amcis Ltd Cash Flow
Month | Mar 2011 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Cash from Operating Activity | 203 | 303 | 226 | 282 | 585 | 513 | 355 | 220 |
Cash from Investing Activity | -231 | -107 | -297 | -169 | -442 | -380 | -619 | -448 |
Cash from Financing Activity | 25 | -137 | 78 | -102 | -98 | -11 | 130 | 250 |
Net Cash Flow | -3 | 59 | 7 | 11 | 46 | 122 | -133 | 22 |
|
Dishman Carbogen Amcis Ltd Financial Efficiency Indicators
Month | Mar 2011 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Debtor Days | 60 | 61 | 96 | 79 | 103 | 80 | 81 | 89 |
Inventory Days | 272 | 473 | 525 | 496 | 462 | 402 | 526 | 574 |
Days Payable | 172 | 95 | 201 | 176 | 226 | 132 | 158 | 157 |
Cash Conversion Cycle | 160 | 439 | 419 | 399 | 340 | 350 | 449 | 506 |
Working Capital Days | 49 | 117 | 129 | 135 | 124 | 135 | 115 | 90 |
ROCE % | | | 5% | 6% | 4% | 0% | 1% | 1% |
Dishman Carbogen Amcis Ltd Financial Efficiency Indicators Chart
No valid data available for the Shareholding
Dishman Carbogen Amcis Ltd Shareholding Pattern Chart
No. of Dishman Carbogen Amcis Ltd Shareholders
Dishman Carbogen Amcis Ltd Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) |
---|
HSBC Flexi Cap Fund | 2377050 | 0.96 | 33.73 |
L&T Flexicap Fund - Regular Plan | 2377050 | 0.81 | 23.47 |
Motilal Oswal Nifty Microcap 250 Index Fund | 63747 | 0.2 | 0.9 |
Motilal Oswal S&P BSE Healthcare ETF | 681 | 0.12 | 0.01 |
Groww Nifty Total Market Index Fund | 149 | 0.01 | 0 |
Dishman Carbogen Amcis Ltd ROCE Trend
Dishman Carbogen Amcis Ltd EPS Trend
Dishman Carbogen Amcis Ltd Key Financial Ratios
Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
---|
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Basic EPS (Rs.) | -1.90 | 1.15 | -10.53 | 10.10 | 13.03 |
Diluted EPS (Rs.) | -1.90 | 1.15 | -10.53 | 10.10 | 13.03 |
Cash EPS (Rs.) | 16.00 | 20.77 | 9.11 | 28.13 | 27.93 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 370.51 | 353.89 | 363.44 | 364.25 | 333.28 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 370.51 | 353.89 | 363.44 | 364.25 | 333.28 |
Revenue From Operations / Share (Rs.) | 153.89 | 136.52 | 121.94 | 130.25 | 127.55 |
PBDIT / Share (Rs.) | 22.96 | 23.90 | 19.95 | 34.55 | 37.53 |
PBIT / Share (Rs.) | 5.05 | 4.29 | 0.30 | 16.52 | 22.64 |
PBT / Share (Rs.) | -3.48 | -0.27 | -4.15 | 12.57 | 19.13 |
Net Profit / Share (Rs.) | -1.90 | 1.15 | -10.53 | 10.10 | 13.03 |
NP After MI And SOA / Share (Rs.) | -1.90 | 1.15 | -10.53 | 10.10 | 13.03 |
PBDIT Margin (%) | 14.91 | 17.50 | 16.35 | 26.52 | 29.42 |
PBIT Margin (%) | 3.28 | 3.13 | 0.25 | 12.68 | 17.74 |
PBT Margin (%) | -2.26 | -0.19 | -3.40 | 9.64 | 15.00 |
Net Profit Margin (%) | -1.23 | 0.84 | -8.63 | 7.75 | 10.21 |
NP After MI And SOA Margin (%) | -1.23 | 0.84 | -8.63 | 7.75 | 10.21 |
Return on Networth / Equity (%) | -0.51 | 0.32 | -2.89 | 2.77 | 3.91 |
Return on Capital Employeed (%) | 1.03 | 0.93 | 0.06 | 3.90 | 5.95 |
Return On Assets (%) | -0.31 | 0.20 | -1.98 | 1.93 | 2.87 |
Long Term Debt / Equity (X) | 0.18 | 0.13 | 0.08 | 0.04 | 0.06 |
Total Debt / Equity (X) | 0.31 | 0.25 | 0.18 | 0.16 | 0.16 |
Asset Turnover Ratio (%) | 0.26 | 0.04 | 0.03 | 0.08 | 0.08 |
Current Ratio (X) | 1.07 | 1.29 | 1.33 | 1.13 | 1.30 |
Quick Ratio (X) | 0.61 | 0.84 | 0.91 | 0.76 | 0.83 |
Inventory Turnover Ratio (X) | 0.86 | 0.29 | 0.22 | 0.47 | 0.55 |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 2.03 | 0.00 |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.73 | 0.00 |
Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 97.97 | 0.00 |
Cash Earning Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 99.27 | 0.00 |
Interest Coverage Ratio (%) | 4.20 | 6.60 | 6.57 | 8.75 | 10.71 |
Interest Coverage Ratio (Post Tax) (%) | 1.21 | 1.57 | -2.00 | 3.56 | 4.72 |
Enterprise Value (Cr.) | 3590.64 | 4151.85 | 2477.79 | 1609.53 | 4166.55 |
EV / Net Operating Revenue (X) | 1.49 | 1.94 | 1.30 | 0.78 | 2.02 |
EV / EBITDA (X) | 9.97 | 11.08 | 7.92 | 2.97 | 6.88 |
MarketCap / Net Operating Revenue (X) | 0.81 | 1.36 | 0.89 | 0.41 | 1.64 |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 97.96 | 0.00 |
Price / BV (X) | 0.33 | 0.52 | 0.29 | 0.14 | 0.62 |
Price / Net Operating Revenue (X) | 0.81 | 1.36 | 0.89 | 0.41 | 1.64 |
EarningsYield | -0.01 | 0.01 | -0.09 | 0.18 | 0.06 |
Dishman Carbogen Amcis Ltd Profitability Ratios (%)
Dishman Carbogen Amcis Ltd Liquidity Ratios
Dishman Carbogen Amcis Ltd Liquidity Ratios (%)
Dishman Carbogen Amcis Ltd Interest Coverage Ratios (%)
Dishman Carbogen Amcis Ltd Valuation Ratios
Fair Value of Dishman Carbogen Amcis Ltd Stock
Fair Value: ₹631.73
The stock is undervalued by 276.03% compared to the current price ₹168
*This is not Investment Advice
Strength and Weakness of Dishman Carbogen Amcis Ltd Stock
Unable to fetch valid data for stock valuation.